H

Researcher Profile

Hans W. Nijman

0000-0002-1821-3042

3

Publications

827

Citations

10

Co-Authors

2

Active Years

Publications

Open Access Journal Article OncoImmunology Jan 01, 2020

Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome

Kim L. Brunekreeft · Sterre T. Paijens · Maartje C.A. Wouters · Fenne L. Komdeur +12 more

10.1080/2162402x.2020.1760705 19 citations

Journal Article Journal of Clinical Oncology Oct 10, 2020

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

Alicia Léon-Castillo · Stephanie M. de Boer · Melanie E. Powell · Linda R. Mileshkin +18 more

10.1200/jco.20.00549 724 citations

Journal Article International Journal of Cancer Jan 31, 2012

Potentiation of a p53‐SLP vaccine by cyclophosphamide in ovarian cancer: A single‐arm phase II study

Renee Vermeij · Ninke Leffers · Baukje‐Nynke Hoogeboom · Ineke L.E. Hamming +12 more

10.1002/ijc.27388 84 citations

Publication Timeline

2020

2

2012

1

Frequent Co-Authors

Emma J. Crosbie

Noor E.J. Pröpper

Vincent T. H. B. M. Smit

Maartje C.A. Wouters

Jan W. Drijfhout

Henry C. Kitchener